• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口服万古霉素使一名原发性硬化性胆管炎且血清免疫球蛋白G4水平升高的患者实现完全生化缓解。

Complete Biochemical Remission With Oral Vancomycin in a Patient With Primary Sclerosing Cholangitis and High Serum Immunoglobulin G4 Levels.

作者信息

Sohal Aalam, Kowdley Kris V

机构信息

Liver Institute Northwest, Seattle, WA.

Elson Floyd College of Medicine, Spokane, WA.

出版信息

ACG Case Rep J. 2024 Jan 16;11(1):e01256. doi: 10.14309/crj.0000000000001256. eCollection 2024 Jan.

DOI:10.14309/crj.0000000000001256
PMID:38236497
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10793982/
Abstract

Primary sclerosing cholangitis (PSC) is a progressive cholestatic liver disease characterized by intrahepatic and extrahepatic bile duct strictures leading to cirrhosis. A subtype with elevated serum immunoglobulin (Ig) G4 levels has been recently identified. Elevated IgG4 titers can be present in 9%-15% of patients with PSC. Currently, liver transplantation is the only effective treatment of PSC, although multiple medical therapies are under evaluation. We report a case of a young adult with PSC and elevated IgG4 levels who had marked serum aminotransferase elevation; the patient had an incomplete response to steroids but achieved complete biochemical remission after initiation of oral vancomycin.

摘要

原发性硬化性胆管炎(PSC)是一种进行性胆汁淤积性肝病,其特征为肝内和肝外胆管狭窄,最终导致肝硬化。最近发现了一种血清免疫球蛋白(Ig)G4水平升高的亚型。9%-15%的PSC患者可出现IgG4滴度升高。目前,肝移植是PSC唯一有效的治疗方法,不过多种药物治疗正在评估中。我们报告一例年轻的PSC成年患者,其IgG4水平升高,血清氨基转移酶显著升高;该患者对类固醇治疗反应不完全,但在开始口服万古霉素后实现了完全生化缓解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4841/10793982/9a6a57c19e65/ac9-11-e01256-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4841/10793982/321c56646556/ac9-11-e01256-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4841/10793982/d95764a279bc/ac9-11-e01256-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4841/10793982/9a6a57c19e65/ac9-11-e01256-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4841/10793982/321c56646556/ac9-11-e01256-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4841/10793982/d95764a279bc/ac9-11-e01256-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4841/10793982/9a6a57c19e65/ac9-11-e01256-g003.jpg

相似文献

1
Complete Biochemical Remission With Oral Vancomycin in a Patient With Primary Sclerosing Cholangitis and High Serum Immunoglobulin G4 Levels.口服万古霉素使一名原发性硬化性胆管炎且血清免疫球蛋白G4水平升高的患者实现完全生化缓解。
ACG Case Rep J. 2024 Jan 16;11(1):e01256. doi: 10.14309/crj.0000000000001256. eCollection 2024 Jan.
2
Primary sclerosing cholangitis with moderately elevated serum-IgG4 - characterization and outcome of a distinct variant phenotype.原发性硬化性胆管炎伴中等升高的血清 IgG4-一种独特表型变异的特征和结局。
Liver Int. 2021 Dec;41(12):2924-2933. doi: 10.1111/liv.15028. Epub 2021 Aug 8.
3
Immunoglobulin G4-related cholangitis: a variant of IgG4-related systemic disease.免疫球蛋白 G4 相关胆管炎:免疫球蛋白 G4 相关全身性疾病的一种变异型。
Dig Dis. 2012;30(2):216-9. doi: 10.1159/000336706. Epub 2012 Jun 20.
4
The long-term outcomes of patients with immunoglobulin G4-related sclerosing cholangitis: the Mayo Clinic experience.免疫球蛋白G4相关性硬化性胆管炎患者的长期预后:梅奥诊所的经验
J Gastroenterol. 2020 Nov;55(11):1087-1097. doi: 10.1007/s00535-020-01714-7. Epub 2020 Aug 8.
5
Clinical clues to suspicion of IgG4-associated sclerosing cholangitis disguised as primary sclerosing cholangitis or hilar cholangiocarcinoma.疑诊 IgG4 相关硬化性胆管炎的临床线索:伪装为原发性硬化性胆管炎或肝门部胆管癌。
J Gastroenterol Hepatol. 2010 Dec;25(12):1831-7. doi: 10.1111/j.1440-1746.2010.06411.x.
6
Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis.血清免疫球蛋白 G4 和免疫球蛋白 G1 用于鉴别 IgG4 相关胆管炎与原发性硬化性胆管炎。
Hepatology. 2014 May;59(5):1954-63. doi: 10.1002/hep.26977. Epub 2014 Apr 1.
7
IgG4 subclass and gamma-glutamyl transferase in children with ulcerative colitis with primary sclerosing cholangitis and without sclerosing cholangitis.患有原发性硬化性胆管炎和未患硬化性胆管炎的溃疡性结肠炎儿童的IgG4亚类和γ-谷氨酰转移酶
Clin Exp Hepatol. 2019 Nov;5(4):285-288. doi: 10.5114/ceh.2019.89119. Epub 2019 Oct 17.
8
The Role of Immunoglobulin G4 in Outcomes of Primary Sclerosing Cholangitis.免疫球蛋白G4在原发性硬化性胆管炎预后中的作用
J Clin Med. 2023 Dec 22;13(1):79. doi: 10.3390/jcm13010079.
9
Elevated immunoglobulin G4 level is associated with reduced colectomy-free survival in patients with primary sclerosing cholangitis and ulcerative colitis.免疫球蛋白 G4 水平升高与原发性硬化性胆管炎和溃疡性结肠炎患者免于结肠切除术的生存时间缩短相关。
J Crohns Colitis. 2013 Mar;7(2):e35-41. doi: 10.1016/j.crohns.2012.04.006. Epub 2012 May 1.
10
Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis.原发性硬化性胆管炎患者血清IgG4浓度升高。
Am J Gastroenterol. 2006 Sep;101(9):2070-5. doi: 10.1111/j.1572-0241.2006.00772.x. Epub 2006 Jul 27.

引用本文的文献

1
All you need to know about the overlap between primary sclerosing cholangitis and inflammatory bowel disease.关于原发性硬化性胆管炎与炎症性肠病重叠的所有你需要了解的信息。
Ann Gastroenterol. 2025 Mar-Apr;38(2):107-120. doi: 10.20524/aog.2025.0945. Epub 2025 Feb 25.

本文引用的文献

1
AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma.美国肝病研究学会关于原发性硬化性胆管炎和胆管癌的实践指南。
Hepatology. 2023 Feb 1;77(2):659-702. doi: 10.1002/hep.32771. Epub 2022 Oct 20.
2
Serum IgG4 cut-off of 70 mg/dL is associated with a shorter time to cirrhosis decompensation and liver transplantation in primary sclerosing cholangitis patients.血清IgG4临界值为70mg/dL与原发性硬化性胆管炎患者肝硬化失代偿和肝移植时间缩短有关。
Can Liver J. 2022 Feb 4;5(1):31-42. doi: 10.3138/canlivj-2021-0023. eCollection 2022 Winter.
3
Successful response of primary sclerosing cholangitis and associated ulcerative colitis to oral vancomycin may depend on brand and personalized dose: report in an adolescent.
原发性硬化性胆管炎及相关溃疡性结肠炎对口服万古霉素的成功反应可能取决于品牌和个性化剂量:一名青少年病例报告
Clin J Gastroenterol. 2021 Apr;14(2):684-689. doi: 10.1007/s12328-020-01296-0. Epub 2020 Nov 24.
4
Oral Vancomycin, Ursodeoxycholic Acid, or No Therapy for Pediatric Primary Sclerosing Cholangitis: A Matched Analysis.口服万古霉素、熊去氧胆酸或无治疗用于小儿原发性硬化性胆管炎:一项匹配分析。
Hepatology. 2021 Mar;73(3):1061-1073. doi: 10.1002/hep.31560.
5
Review of primary sclerosing cholangitis with increased IgG4 levels.IgG4水平升高的原发性硬化性胆管炎综述
World J Gastroenterol. 2020 Jun 21;26(23):3126-3144. doi: 10.3748/wjg.v26.i23.3126.
6
A pilot study of fecal bile acid and microbiota profiles in inflammatory bowel disease and primary sclerosing cholangitis.炎症性肠病和原发性硬化性胆管炎患者粪便胆汁酸及微生物群谱的一项初步研究。
Clin Exp Gastroenterol. 2019 Jan 10;12:9-19. doi: 10.2147/CEG.S186097. eCollection 2019.
7
Efficacy of oral vancomycin in recurrent primary sclerosing cholangitis following liver transplantation.肝移植后复发性原发性硬化性胆管炎口服万古霉素的疗效
BMJ Case Rep. 2017 Sep 25;2017:bcr-2017-221165. doi: 10.1136/bcr-2017-221165.
8
The "gut microbiota" hypothesis in primary sclerosing cholangitis.原发性硬化性胆管炎中的“肠道微生物群”假说。
Ann Transl Med. 2016 Dec;4(24):512. doi: 10.21037/atm.2016.12.43.
9
Elevated Serum IgG4 Levels in Diagnosis, Treatment Response, Organ Involvement, and Relapse in a Prospective IgG4-Related Disease UK Cohort.在 IgG4 相关疾病英国队列前瞻性研究中,血清 IgG4 水平升高与诊断、治疗反应、器官受累和复发有关。
Am J Gastroenterol. 2016 May;111(5):733-43. doi: 10.1038/ajg.2016.40. Epub 2016 Apr 19.
10
ACG Clinical Guideline: Primary Sclerosing Cholangitis.美国胃肠病学会临床指南:原发性硬化性胆管炎
Am J Gastroenterol. 2015 May;110(5):646-59; quiz 660. doi: 10.1038/ajg.2015.112. Epub 2015 Apr 14.